Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis

被引:112
作者
Munsch, D
Watanabe-Fukunaga, R
Bourdon, JC
Nagata, S
May, E
Yonish-Rouach, E
Reisdorf, P
机构
[1] CEA, Lab Cancerol Mol, Dept Radiobiol & Radiopathol, Direct Sci Vie,CNRS,UMR 217, F-92265 Fontenay Aux Roses, France
[2] Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan
关键词
D O I
10.1074/jbc.275.6.3867
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p53 is a tumor suppressor protein that induces apoptosis at least in part through its ability to act as a sequence-specific transactivator. This work reports that intron 1 of the mouse Fas death receptor gene contains a p53-responsive element (p53RE) that matches the p53 consensus sequence and that is located between nucleotides +1704 and +1723 from the transcription initiation site. This element is specifically bound by p53 and functions as a p53-dependent enhancer in mammalian or in yeast reporter gene assays. Contrary to bax, another known pro-apoptotic p53-target gene, both mouse and human FAS p53REs are still activated by the discriminatory P53 mutants Pro-175 and Ala-143, a class of mutants unable to induce apoptosis. We propose that p53-dependent up-regulation of Fas does not induce apoptosis per se but sensitizes the cell to other pro-apoptotic signal(s). The functional conservation of p53-dependent Fas up-regulation argues strongly in favor of its biological importance and suggests that murine models may be used to study further the in vivo role of Fas in the p53 response.
引用
收藏
页码:3867 / 3872
页数:6
相关论文
共 52 条
  • [31] OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032
  • [32] SEQUENCE-SPECIFIC TRANSCRIPTIONAL ACTIVATION IS ESSENTIAL FOR GROWTH SUPPRESSION BY P53
    PIETENPOL, JA
    TOKINO, T
    THIAGALINGAM, S
    ELDEIRY, WS
    KINZLER, KW
    VOGELSTEIN, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 1998 - 2002
  • [33] A model for p53-induced apoptosis
    Polyak, K
    Xia, Y
    Zweier, JL
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1997, 389 (6648) : 300 - 305
  • [34] DNA-BINDING PROPERTIES OF THE P53 TUMOR-SUPPRESSOR PROTEIN
    PRIVES, C
    BARGONETTI, J
    FARMER, G
    FERRARI, E
    FRIEDLANDER, P
    WANG, Y
    JAYARAMAN, L
    PAVLETICH, N
    HUBSCHER, U
    [J]. COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1994, 59 : 207 - 213
  • [35] TRANSCRIPTIONAL ACTIVATION BY WILD-TYPE BUT NOT TRANSFORMING MUTANTS OF THE P53 ANTIONCOGENE
    RAYCROFT, L
    WU, H
    LOZANO, G
    [J]. SCIENCE, 1990, 249 (4972) : 1049 - 1051
  • [36] The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo
    Reinke, V
    Lozano, G
    [J]. ONCOGENE, 1997, 15 (13) : 1527 - 1534
  • [37] RESNICKSILVERMA.L, 1998, GENES DEV, V15
  • [38] Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant
    Rowan, S
    Ludwig, RL
    Haupt, Y
    Bates, S
    Lu, X
    Oren, M
    Vousden, KH
    [J]. EMBO JOURNAL, 1996, 15 (04) : 827 - 838
  • [39] RUBY SW, 1983, METHOD ENZYMOL, V101, P253
  • [40] Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest
    Ryan, KM
    Vousden, KH
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) : 3692 - 3698